Should laboratories test methicillin-resistant Staphylococcus aureus for elevated vancomycin minimum inhibitory concentrations by Etest as a driver of treatment changes?

Clin Infect Dis. 2012 Aug;55(4):612-3. doi: 10.1093/cid/cis469. Epub 2012 May 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / mortality*
  • Vancomycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Vancomycin